Literature DB >> 9298759

Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variation.

C McGuigan1, H W Tsang, D Cahard, K Turner, S Velazquez, A Salgado, L Bidois, L Naesens, E De Clercq, J Balzarini.   

Abstract

Phosphoramidate derivatives of the nucleoside analogue, 2',3'-dideoxy-2',3'-didehydro thymidine (d4T) have been prepared as potential membrane-soluble pro-drugs of the big-active free phosphate forms. In particular phenyl phosphates, linked via nitrogen to methyl-esterified amino acids, were studied. All compounds were fully characterised by a range of methods (high-field multinuclear NMR, mass spectrometry and high performance liquid chromatography (HPLC)) and were subjected to in vitro evaluation of their anti-HIV efficacy. The nature of the amino acid appeared to be extremely important for the eventual antiviral action. Of the amino acids studied, L-alanine was the most efficacious, whilst L-proline and glycine were particularly poor. However, an unnatural amino acid moiety, dimethylglycine, could substitute for alanine with little or no loss of activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298759     DOI: 10.1016/s0166-3542(97)00029-6

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  10 in total

1.  Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.

Authors:  Fatih M Uckun; Sharon Pendergrass; T K Venkatachalam; Sanjive Qazi; Douglas Richman
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 2.  Synthesis of nucleoside phosphate and phosphonate prodrugs.

Authors:  Ugo Pradere; Ethel C Garnier-Amblard; Steven J Coats; Franck Amblard; Raymond F Schinazi
Journal:  Chem Rev       Date:  2014-08-21       Impact factor: 60.622

3.  [d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase.

Authors:  Yassir Younis; Roger Hunter; Clare I Muhanji; Ian Hale; Rajinder Singh; Christopher M Bailey; Todd J Sullivan; Karen S Anderson
Journal:  Bioorg Med Chem       Date:  2010-05-11       Impact factor: 3.641

Review 4.  Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues.

Authors:  Larryn W Peterson; Charles E McKenna
Journal:  Expert Opin Drug Deliv       Date:  2009-04       Impact factor: 6.648

5.  The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.

Authors:  Marco Derudas; Davide Carta; Andrea Brancale; Christophe Vanpouille; Andrea Lisco; Leonid Margolis; Jan Balzarini; Christopher McGuigan
Journal:  J Med Chem       Date:  2009-09-10       Impact factor: 7.446

6.  Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospray ionization tandem mass spectrometry.

Authors:  Amin M Kamel; Burnaby Munson
Journal:  J Am Soc Mass Spectrom       Date:  2007-05-10       Impact factor: 3.109

Review 7.  Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.

Authors:  Magdalena Slusarczyk; Michaela Serpi; Fabrizio Pertusati
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

8.  Design, synthesis and biological evaluation of 2'-deoxy-2',2'-difluoro-5-halouridine phosphoramidate ProTides.

Authors:  Maurizio Quintiliani; Leentje Persoons; Nicola Solaroli; Anna Karlsson; Graciela Andrei; Robert Snoeck; Jan Balzarini; Christopher McGuigan
Journal:  Bioorg Med Chem       Date:  2011-05-27       Impact factor: 3.641

9.  Phosphoramidates of 2'-beta-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism.

Authors:  Youcef Mehellou; Rocco Valente; Huw Mottram; Elisabeth Walsby; Kenneth I Mills; Jan Balzarini; Christopher McGuigan
Journal:  Bioorg Med Chem       Date:  2010-03-01       Impact factor: 3.641

Review 10.  The ProTide Prodrug Technology: From the Concept to the Clinic.

Authors:  Youcef Mehellou; Hardeep S Rattan; Jan Balzarini
Journal:  J Med Chem       Date:  2017-08-24       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.